CELLECTIS S.A.

In News

Cellectis Bets on Non-Viral Editing for Therapy Gains - CRISPR Medicine News

CRISPR Medicine News - Jan 28, 2026

AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology - Reuters

Reuters - Sep 26, 2025

Earnings To Watch: Cellectis SA (CLLS) Reports Q2 2025 Result - Yahoo Finance

Yahoo Finance - Aug 04, 2025

Individual investors invested in Cellectis S.A. (EPA:ALCLS) copped the brunt of last week's €35m market cap decline - simplywall.st

simplywall.st - Jan 15, 2026

Cellectis’ Allogeneic CAR-T Potential Still Justifies A “Buy” (NASDAQ:CLLS) - Seeking Alpha

Seeking Alpha - Dec 11, 2025

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

GlobeNewswire - Nov 07, 2025

Cellectis S.A. Updates Patent License Agreement with University of Minnesota - TipRanks

TipRanks - Dec 05, 2025

Factor Bioscience Files Complaint Against Cellectis and AstraZeneca Alleging Infringement of Foundational Gene-Editing Patents - PR Newswire

PR Newswire - Sep 26, 2025

AstraZeneca, Cellectis Sued Over $2.2 Billion Cancer-Drug Deal - Bloomberg Law News

Bloomberg Law News - Sep 26, 2025

Can Cellectis S.A. Depositary Receipt expand into new markets - Earnings Risk Summary & Risk Adjusted Buy/Sell Alerts - mfd.ru

mfd.ru - Feb 12, 2026

Cellectis’s SWOT analysis: gene therapy firm’s stock poised for growth? - Investing.com

Investing.com - Oct 08, 2025

CLLS: Analyst Raises Price Target Significantly for Cellectis | CLLS Stock News - GuruFocus

GuruFocus - Oct 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment